Camson Bio Technologies Limited announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2018. For the quarter, the company reported total income of INR 38.933 million against INR 40.813 million a year ago. Loss for the year was INR 6.480 million against INR 55.840 million a year ago. Basic loss per equity share was INR 0.22 against INR 1.86 a year ago. Revenue from operations was INR 15.794 million against INR 38.534 million a year ago. For the nine months, the company reported total income of INR 67.655 million against INR 213.556 million a year ago. Loss for the year was INR 105.958 million against INR 63.139 million a year ago. Basic loss per equity share was INR 3.53 against INR 2.10 a year ago. Revenue from operations was INR 43.884 million against INR 198.196 million a year ago.